7-96170044-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_014251.3(SLC25A13):c.1311+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000143 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_014251.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251280Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135810
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461696Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727178
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
Citrullinemia type II Pathogenic:1Other:1
- -
- -
Neonatal intrahepatic cholestasis due to citrin deficiency Pathogenic:1
The observed invariant splice donor c.1311+1G>A variant in SLC25A13 gene has been reported previously reported in multiple individuals affected with citrin deficiency (Kobayashi et al., 1999; Kobayashi et al., 2003 Hirayama et al., 2018). The c.1311+1G>A variant is present with allele frequency of 0.0004% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic. Loss of function variants in SLC25A13 gene have been previously reported to be disease causing (Lin et al., 2016). For these reasons, this variant has been classified as Pathogenic. -
Citrin deficiency Pathogenic:1
This sequence change affects a donor splice site in intron 13 of the SLC25A13 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SLC25A13 are known to be pathogenic (PMID: 10369257, 14680984, 27405544). This variant is present in population databases (rs80338723, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with citrin deficiency (PMID: 10369257, 29659898). This variant is also known as IVS13+1G>A. ClinVar contains an entry for this variant (Variation ID: 6005). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Citrullinemia, type II, adult-onset Pathogenic:1
- -
Late-onset citrullinemia Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at